Giuseppe Lo Russo

Tumori Foundation — United States

Medicine · Health Sciences

37h-index4.7kcitations330works2.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(129), Lung Cancer Treatments and Mutations(99), Lung Cancer Research Studies(60), Cancer Genomics and Diagnostics(35), Lung Cancer Diagnosis and Treatment(29)

Publications330 total

A phase III placebo-controlled study of eftilagimod alfa plus pembrolizumab and chemotherapy in metastatic non-small cell lung cancer
Future Oncology·2025Open Access
Treatment response after induction therapy in advanced thymic tumors: results from the Italian nationwide TYME database
Lung Cancer·2025
Angiogenesis and thymic epithelial tumors: from preclinical insights to different therapeutic lines and combination strategies
Cancer Treatment Reviews·2025
417P Benchmarking digital pathology foundation models on PD-L1 slides for immunotherapy response classification
ESMO Real World Data and Digital Oncology·2025Open Access
71MO Collaborative human-agent for therapeutic decision-making in cancer immunotherapy prediction
ESMO Real World Data and Digital Oncology·2025Open Access
Abstract C072: Comparing and combining existing radiological criteria for hyperprogressive disease in patients receiving immune-oncology therapy: Building towards a sensitive and conservative method to assess the presence of hyperprogressive disease
Molecular Cancer Therapeutics·2025
Combining Clinician Expertise with Prompt Engineering enhances Small Language Models Reliability for Cancer Entity Recognition in Electronic Health Records
2025Open Access
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity
Lung Cancer·2025Open Access
P1.04.51 Exploring the Potential of Multimodal Cough Analysis as a Pre-Screening Tool for Non-Small Cell Lung Cancer Detection
Journal of Thoracic Oncology·2025
P2.15.34 Prompting and Medical Expertise Influence Large Language Model in Clinical Data Extraction: Findings From the APOLLO 11 Trial
Journal of Thoracic Oncology·2025
P1.17.55 Transforming Prognostication: A 5-Year Follow-Up Study to Unravel Prognostic Predictors Across Age Groups in NSCLC Using Transformer-Based AI
Journal of Thoracic Oncology·2025
PL02.12 Ivonescimab vs Placebo Plus Chemo, Phase 3 in Patients with EGFR+ NSCLC Progressed with 3rd gen EGFR-TKI Treatment: HARMONi
Journal of Thoracic Oncology·2025· 4 cited
P3.12.10 Adapting RECIST for Real-World Data: Independent Imaging Read Methodology Over Successive Treatments in a NSCLC Data Registry
Journal of Thoracic Oncology·2025Open Access
P3.14.18 The Role of Induction Therapy Followed by Surgery in Advanced Thymic Epithelial Tumors: A Systematic Review and Meta-Analysis
Journal of Thoracic Oncology·2025
Long-term Survival Analysis From PERLA, A Phase II Randomized Trial of Dostarlimab With Chemotherapy Versus Pembrolizumab With Chemotherapy in Metastatic Nonsquamous NSCLC
JTO Clinical and Research Reports·2025Open Access
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry
Journal for ImmunoTherapy of Cancer·2025· 1 citedOpen Access
2081eTiP KEYMAKER-U01 phase II substudies 01H/01I: Ifinatamab deruxtecan (I-DXd), raludotatug deruxtecan (R-DXd), or docetaxel in stage IV non-small cell lung cancer (NSCLC)
Annals of Oncology·2025
2983P Patients with thymic malignancies: Report from the Italian TYME rare cancers network
Annals of Oncology·2025
2982P Integrative transcriptomic and machine-learning analysis identifies prognostic clusters in epithelioid pleural mesothelioma
Annals of Oncology·2025Open Access
Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial
The Lancet·2025· 18 cited
page 1 of 17Next →

Frequent Co-authors

Marina Chiara Garassino(29), Diego Signorelli(26), Claudia Proto(24), Filippo de Braud(21), Monica Ganzinelli(18), Giulia Galli(16), Roberto Ferrara(14), Alessandro De Toma(12), Arsela Prelaj(11), Martina Imbimbo(11), Nicoletta Zilembo(10), Federica Tomao(9), Milena Vitali(9), Valter Torri(8), Giuseppe Viscardi(6), Marta Brambilla(6), Rosaria Gallucci(6), Domenico Galetta(5), Marianna Macerelli(5), Giulia Corrao(5)